1501 Long-term safety of belimumab among adult patients with systemic lupus erythematosus (SLE): pooled data from three open-label extension studies over 11+ years

• Munther Khamashta,
• Ricard Cervera,
• Daniel J Wallace,
• Maria G Tektonidou,
• Tatsuya Atsumi,
• Paula Curtis,
• Christine Henning,
• Aneela N Mian

Affiliations

Munther Khamashta

1Queen Elizabeth II Health Sciences Center and Dalhousie University, Rheumatology/Medicine, Halifax, Nova Scotia, Canada

Ricard Cervera

2University of Barcelona, Department of Autoimmune Diseases, Barcelona, Catalonia, Spain

Daniel J Wallace

6Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Maria G Tektonidou

Cardiovascular Risk Research Laboratory, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

Tatsuya Atsumi

2Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Rheumatology, Endocrinology and Nephrology, Sapporo, Japan

Paula Curtis

GlaxoSmithKline, Brentford, Middlesex, UK

Christine Henning

Global Medical Affairs, GSK, Durham, North Carolina, USA

Aneela N Mian

1Global Medical Affairs, GSK, Brentford, UK